Joon H. Uhm, MD

Department of Neurology and Division of Neuro-Oncology,
Mayo Clinic, Rochester, MN

Alyx B. Porter, MD

Department of Neurology,
Mayo Clinic, Scottsdale, AZ

Accredited by

Mayo Clinic

View Activity Materials

Course Description

Learning Objectives: On completion of this article, you should be able to: (1) identify molecular markers that play a role in the understanding of response to therapy in patients with high grade glioma; (2) contrast the treatment options available and their efficacy in patients with high grade glioma and various molecular signatures; and (3) recognize the larger clinical trials that have been conducted that shape the practice for the current management of high grade glioma.

Activity Details

Credit Types:CME
Credit Amount:1.00 Credits
Release Date:2017-Jun-01
Expiration Date:2019-May-31
Estimated Time for Completion:1 hour
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.